Home › Compare › EMYIF vs JNJ

EMYIF vs JNJ: Dividend Comparison 2026

EMYIF yields 16.13% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMYIF wins by $37.4K in total portfolio value
10 years
EMYIF
EMYIF
● Live price
16.13%
Share price
$12.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.4K
Annual income
$4,351.13
Full EMYIF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EMYIF vs JNJ

📍 EMYIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMYIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMYIF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMYIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMYIF
Annual income on $10K today (after 15% tax)
$1,370.97/yr
After 10yr DRIP, annual income (after tax)
$3,698.46/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EMYIF beats the other by $2,994.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMYIF + JNJ for your $10,000?

EMYIF: 50%JNJ: 50%
100% JNJ50/50100% EMYIF
Portfolio after 10yr
$38.7K
Annual income
$2,589.46/yr
Blended yield
6.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EMYIF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMYIF buys
0
JNJ buys
0
No recent congressional trades found for EMYIF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMYIFJNJ
Forward yield16.13% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$57.4K ✓$20.0K
Annual income after 10y$4,351.13 ✓$827.78
Total dividends collected$29.0K ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMYIF vs JNJ ($10,000, DRIP)

YearEMYIF PortfolioEMYIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,313$1,612.90$10,676$355.77+$1.6K → EMYIF
2$15,031$1,856.03$11,407$389.39+$3.6K → EMYIF
3$18,200$2,117.50$12,198$426.53+$6.0K → EMYIF
4$21,871$2,396.29$13,056$467.62+$8.8K → EMYIF
5$26,093$2,691.15$13,987$513.12+$12.1K → EMYIF
6$30,920$3,000.63$14,998$563.56+$15.9K → EMYIF
7$36,408$3,323.12$16,098$619.52+$20.3K → EMYIF
8$42,613$3,656.91$17,295$681.69+$25.3K → EMYIF
9$49,596$4,000.19$18,599$750.82+$31.0K → EMYIF
10$57,419$4,351.13$20,022$827.78+$37.4K → EMYIF

EMYIF vs JNJ: Complete Analysis 2026

EMYIF — Stock

Euromoney Institutional Investor PLC, together with its subsidiaries, provides business-to-business information services in the United Kingdom, North America, and internationally. The company operates through three segments: Fast Markets, Financial & Professional Services, and Asset Management. The Fast Market segment provides commodity price benchmarks and analysis to its clients' business processes and workflows in the metals, mining, forest products, and agriculture industries. The Financial & Professional Services segment offers actionable data, market and people intelligence, accreditation, marketing, and event services to financial and professional services businesses. The Asset Management segment provides independent research that enables its customers to make informed investment decisions; runs networks and conferences that bring asset allocators and managers together; and offers news and data for the industry to stay informed and make deals. It also engages in the research and data service, publishing, property holding activities. The company was formerly known as Euromoney Publications PLC and changed its name to Euromoney Institutional Investor PLC in April 1999. The company was incorporated in 1969 and is headquartered in London, the United Kingdom. As of November 24, 2022, Euromoney Institutional Investor PLC was taken private.

Full EMYIF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EMYIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMYIF vs SCHDEMYIF vs JEPIEMYIF vs OEMYIF vs KOEMYIF vs MAINEMYIF vs ABBVEMYIF vs MRKEMYIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.